Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BioNTech SE - ADR (BNTX) vs Lufax Holding Ltd (LU) Price & Performance

BioNTech SE - ADRTrade
Lufax Holding LtdTrade

Price performance (Past 24H)

Key statistics

BioNTech SE - ADR vs Lufax Holding Ltd — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Lufax Holding Ltd trades at $1.56 (market cap $2.41B). The key difference: BioNTech SE - ADR is far larger — about 9.7× Lufax Holding Ltd's market cap, and BioNTech SE - ADR is trading nearer its 52-week high, Lufax Holding Ltd nearer its low. Which is the better fit depends on your goals.

BNTXLU
Market Cap
$23.31B$2.41B
Sector
HealthTechnology
52-Week High
$119.34$4.40
52-Week Low
$83.89$1.23
Enterprise Value
$6.60B

Returns comparison

Trailing returns across standard periods

About BioNTech SE - ADR

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.

Read more on BNTX

About Lufax Holding Ltd

Lufax Holding Ltd is a leading financial technology (fintech) platform in China. The company operates a technology-driven personal financial services platform that offers a wide range of loans and wealth management products to its users. Lufax primarily serves the rapidly growing wealth and consumption needs of China’s mass affluent and affluent populations through a combination of its digital platform and an extensive offline network.

Read more on LU